Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:56pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report) today and set a price
Needham Thinks Flexion Therapeutics' Stock is Going to Recover
03:21pm, Wednesday, 01'st Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Flexion Therapeutics (FLXN), with a price target of $36.00. The
Needham Thinks Flexion Therapeutics’ Stock is Going to Recover
03:21pm, Wednesday, 01'st Apr 2020
In a report released today,
Serge Belanger
from Needham maintained a
Buy
rating on Flexion Therapeutics (
FLXN
–
Research Report
), with a price target of
$36.00
. The company’s shares closed last
Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
02:56pm, Tuesday, 31'st Mar 2020
Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call
Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified?
12:36pm, Sunday, 29'th Mar 2020
In 1996 Jack Zhang was appointed CEO of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). This analysis aims first to...
Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
06:46pm, Saturday, 28'th Mar 2020
Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
11:34am, Friday, 27'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL), with a price target of $38.00. The
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
11:34am, Friday, 27'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report),
Needham Sticks to Their Buy Rating for Aerie Pharma (AERI)
11:27am, Friday, 27'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Sticks to Their Buy Rating for Aerie Pharma (AERI)
11:27am, Friday, 27'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Aerie Pharma (
AERI
–
Research Report
) today and set a price target of
$40.00
. The company’s shares closed last Monday at $13.50, close
Needham Sticks to Its Buy Rating for Revance Therapeutics (RVNC)
09:54am, Friday, 27'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Revance Therapeutics (RVNC) today and set a price target of $36.00. The company's shares closed
Needham Sticks to Its Buy Rating for Revance Therapeutics (RVNC)
09:54am, Friday, 27'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Revance Therapeutics (RVNC – Research Report) today and set a price
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
01:33pm, Wednesday, 25'th Mar 2020
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
01:33pm, Wednesday, 25'th Mar 2020
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
